23 May 2024 : Database Analysis
MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB
Yongyuan Zheng1ABCD, Yansong Huang1CDE, Weibing Li1CD, Hongqiu Cheng1AEG*DOI: 10.12659/MSM.944685
Med Sci Monit 2024; 30:e944685
Figure 2 The expression level of MRTO of HCC patients with different clinical characteristics in TCGA. (A) pathologic T stage, (B) histologic grade, (C) vascular invasion, (D) BMI, (E) weight, (F) tumor status, (G) AFP, (H) OS event, (I) DSS event. * P<0.05, ** P<0.01, *** P<0.001.






